In a filing, Idexx Laboratories, Inc revealed its Director Vandebroek Sophie V. unloaded Company’s shares for reported $0.14 million on Nov 27 ’24. In the deal valued at $420.44 per share,344 shares were sold. As a result of this transaction, Vandebroek Sophie V. now holds 905 shares worth roughly $0.4 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Vandebroek Sophie V. bought 344 shares, generating $144,630 in total proceeds.
Before that, SZOSTAK M ANNE sold 500 shares. Idexx Laboratories, Inc shares valued at $234,686 were divested by the Director at a price of $469.37 per share. As a result of the transaction, SZOSTAK M ANNE now holds 0 shares, worth roughly $0.0.
Leerink Partners initiated its Idexx Laboratories, Inc [IDXX] rating to an Outperform in a research note published on December 02, 2024; the price target was $500. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Piper Sandler also remained covering IDXX and has decreased its forecast on January 30, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Exane BNP Paribas started covering the stock on December 07, 2023. It rated IDXX as “an Outperform”.
Price Performance Review of IDXX
On Tuesday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock fall -1.32% to $444.72. Over the last five days, the stock has gained 2.92%. Idexx Laboratories, Inc shares have fallen nearly -19.88% since the year began. Nevertheless, the stocks have fallen -16.30% over the past one year. While a 52-week high of $583.39 was reached on 03/01/24, a 52-week low of $398.50 was recorded on 11/21/24. SMA at 50 days reached $443.82, while 200 days put it at $487.59.
Levels Of Support And Resistance For IDXX Stock
The 24-hour chart illustrates a support level at 440.66, which if violated will result in even more drops to 436.60. On the upside, there is a resistance level at 450.49. A further resistance level may holdings at 456.26. The Relative Strength Index (RSI) on the 14-day chart is 56.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 15.15, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.60%. Stochastics %K at 91.32% indicates the stock is a selling.
How much short interest is there in Idexx Laboratories, Inc?
A steep rise in short interest was recorded in Idexx Laboratories, Inc stocks on 2024-11-29, dropping by -0.87 million shares to a total of 1.2 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 2.08 million shares. There was a decline of -72.71%, which implies that there is a negative sentiment for the stock.
